Annual Report

Overview

The report is the company's first ESG report for FY2017. It describes a stakeholder-led materiality assessment that prioritizes packaging materials, electricity, hazardous waste, product responsibility, development and training, employee benefits, and health and safety. The Group reported 1,839 employees and continued expanding its generic and proprietary medicines businesses through acquisitions, production investment and R&D.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2017
Period: Ends 31 March 2017
Publication date: 23 June 2017
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services